Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Audited Financial Results & Dividend

 This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and 3. Re-appointed, based on the recommendation of the Audit Committee, S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.
20-05-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Audited Financial Results For The Year Ended 31St March, 2022

 This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and 3. Re-appointed, based on the recommendation of the Audit Committee, S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.
20-05-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit Annual Secretarial Compliance Report from a practicing Company Secretary, for the year ended 31st March, 2022. This is for your information and record.
04-05-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Certificate From A Practicing Company Secretary Under Regulation 40(9)

 Pursuant to Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the financial year ended 31st March, 2022, within 30 days of the date of lodgment for transfer, sub-division, consolidation etc.
19-04-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th April, 2022, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 31st March, 2022.
14-04-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholder. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Rajiv Gupta Jt. Sunita Gupta 25421 300 23134 25307 59002 69733201-69733300 69950501-69950600 74053701-74053800 209384 This is for your information and record.
31-03-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st April, 2022 till 48 hours after the declaration of audited financial results for the quarter / year ending 31st March, 2022. The date of the Board Meeting to consider the audited financial results for the quarter / financial year ending 31st March, 2022, shall be intimated separately. This is for your information and record.
30-03-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 12th March, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Rajiv Gupta Jt. Sunita Gupta 25421 300 23134 25307 59002 69733201-69733300 69950501-69950600 74053701-74053800 This is for your information and record.
14-03-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Financial Results For The Quarter Ended 31St December 2021

 The Board of Directors of the Company, at their meeting held on 8th February, 2022, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.55 p.m.
08-02-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2021

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 8th February, 2022, inter-alia to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2021. This is for your information and record.
29-01-2022
Next Page
Close

Let's Open Free Demat Account